Home › Trial NCT00070382
Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer
- Trial IDNCT00070382
- StatusCompleted
- PhasePhase 3
- Study typeInterventional
- SponsorJonsson Comprehensive Cancer Center
- Enrollment14
- Start date2003-08
- ConditionsAnemia · Leukemia · Lymphoma · Lymphoproliferative Disorder · Multiple Myeloma and Plasma Cell Neoplasm · Precancerous/Nonmalignant Condition
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.